{
  "id": "6422ee03690f196b51000046",
  "type": "factoid",
  "question": "What cells produce erythroferrone?",
  "ideal_answer": "The cells that produce erythroferrone are erythroid cells or erythroblasts.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/35628152",
    "http://www.ncbi.nlm.nih.gov/pubmed/31649559",
    "http://www.ncbi.nlm.nih.gov/pubmed/34772005",
    "http://www.ncbi.nlm.nih.gov/pubmed/31723763",
    "http://www.ncbi.nlm.nih.gov/pubmed/34002695",
    "http://www.ncbi.nlm.nih.gov/pubmed/28739636",
    "http://www.ncbi.nlm.nih.gov/pubmed/30097509",
    "http://www.ncbi.nlm.nih.gov/pubmed/35464433",
    "http://www.ncbi.nlm.nih.gov/pubmed/34614145",
    "http://www.ncbi.nlm.nih.gov/pubmed/24880340",
    "http://www.ncbi.nlm.nih.gov/pubmed/31899794"
  ],
  "snippets": [
    {
      "text": ". Erythroferrone, a factor produced and secreted by erythroid precursors in response to erythropoietin, has been identified and characterized as a suppressor of hepcidin synthesis to allow iron mobilization and facilitate erythropoiesis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35628152",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The hormone erythroferrone (ERFE) is produced by erythroid cells in response to hemorrhage, hypoxia, or other erythropoietic stimuli, and it suppresses the hepatic production of the iron-regulatory hormone hepcidin",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34614145",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Erythroid overproduction of erythroferrone causes iron overload and developmental abnormalities in mice.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34614145",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Here the hormone erythroferrone, produced by erythroblasts, acts on hepatocytes to suppress hepcidin production, and thereby increase dietary iron absorption and mobilization from stores.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31723763",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Erythroferrone is a recently identified erythroid regulator produced by erythroblasts in the mammalian bone marrow and extramedullary sites, known to be induced in conditions of anemia or blood loss.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35464433",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The hormone erythroferrone (ERFE) is produced by erythroid cells in response to hemorrhage, hypoxia, or other erythropoietic stimuli, and it suppresses the hepatic production of the iron-regulatory hormone hepcidin, thereby mobilizing iron for erythropoiesis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34614145",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Erythroferrone (ERFE) is produced by erythroblasts in response to erythropoietin (EPO) and acts in the liver to prevent hepcidin stimulation by BMP6.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31899794",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Erythroferrone (ERFE) is a glycoprotein hormone secreted by erythroblasts in response to stimulation by erythropoietin (EPO).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28739636",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Erythroferrone (ERFE) is an iron-regulatory hormone which is highly expressed in erythroblasts by erythropoietin (EPO) stimulation and osteoblasts independently of EPO by sequestering bone morphogenetic proteins and inhibiting hepatic hepcidin expression.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34772005",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ERFE is produced by erythroblasts in response to erythropoietin.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24880340",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " ERFE is produced by erythroblasts in response to erythropoietin.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24880340",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Erythropoietin (EPO) enhances erythroferrone (ERFE) synthesis by erythroblasts, and ERFE suppresses hepatic hepcidin production through an unknown mechanism.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30097509",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "pcidin suppression during stress erythropoiesis. ERFE is produced by erythroblasts in response to erythropoietin. ERFE-deficient mice fail to suppress",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24880340",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Erythroferrone, a factor produced and secreted by erythroid precursors in response to erythropoietin, has been identified and characterized as a suppressor of hepcidin synthesis to allow iron mobilization and facilitate erythropoiesis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35628152",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The paradigm is non-transfusion-dependent thalassemia where the release of erythroferrone from the expanded pool of immature erythroid cells results in hepcidin suppression and secondary iron overload that in turn worsens ineffective erythropoiesis and anemia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31649559",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Decreased hepcidin mobilizes iron, which facilitates erythropoiesis, but excess iron is pathogenic in \u03b2-thalassemia. Erythropoietin (EPO) enhances erythroferrone (ERFE) synthesis by erythroblasts, and ERFE suppresses hepatic hepcidin production through an unknown mechanism. The BMP/SMAD pathway in the liver is critical for hepcidin control, and we show that EPO suppressed hepcidin and other BMP target genes in vivo in a partially ERF",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30097509",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Background: Erythroblast erythroferrone (ERFE) secretion inhibits hepcidin expression by sequestering several bone morphogenetic protein (BMP) family members to increase iron availability for erythropoiesis.Methods: To address whether ERFE functions also in bone and whether the mechanism of ERFE action in bone involves BMPs, we utilize the Erfe-/- mouse model as well as \u03b2-thalassemic (Hbbth3/+) mice with systemic loss",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34002695",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "erythroid precursors, Erythroblasts"
}